DefinitionThis section has been translated automatically.
ContraindicationThis section has been translated automatically.
Contraindications for medication: Pregnancy ciphers according to "Red List | |
Group | Assessment |
1 | Extensive use in humans did not give rise to any suspicion of an embryotoxic/teratogenic effect. Animal testing also did not provide any evidence of embryotoxic/teratogenic effects |
2 | Extensive use in humans did not give rise to any suspicion of an embryotoxic/teratogenic effect. |
3 | Extensive use in humans did not give rise to any suspicion of an embryonic/teratogenic effect. However, animal experiments also yielded indications of embryotoxic/teratogenic effects. These appear to be of no significance for humans. |
4 | There is insufficient experience of its use in humans. Animal experiments have not shown any evidence of embryotoxic/teratogenic effects. |
5 | There is insufficient experience of its use in humans. |
6 | There is insufficient experience of its use in humans. Animal experiments have shown evidence of embryotoxic/teratogenic effects. |
7 | There is an embryotoxic/teratogenic risk in humans (1st trimenon) |
8 | There is a fetotoxic risk in humans (2nd and 3rd trimester). |
9 | There is a risk of perinatal complications or damage in humans. |
10 | There is a risk of undesirable hormone-specific effects on the fruit in humans. |
11 | There is a risk of mutagenic/carcinogenic effects. |
You might also be interested in
Note(s)This section has been translated automatically.
LiteratureThis section has been translated automatically.
- Schaefer C, Spielmann H (2001) Prescription of drugs during pregnancy and lactation. 6th edition, Urban & Fischer, S. 32-582
- Wohlrab J (2010) Dermatotherapy in pregnancy dermatologist 61: 1045-1051
TablesThis section has been translated automatically.
Pharmaceuticals |
Embryonic period (1st-12th week of gestation) |
Fetal period (from 13th week of gestation) |
Peripartum period |
Lactation period |
ACE inhibitors |
2 |
T |
T |
2 |
Acetylcysteine |
1 |
1 |
1 |
1 |
Acetylsalicylic acid (low-dose unlimited) |
2/E |
2/E |
2/E |
2/E |
Aciclovir |
2 |
2 |
2 |
2 |
Acitretin |
K |
K |
K |
K |
Ambroxol |
1 |
1 |
1 |
1 |
Aminoglycosides |
T |
T |
T |
2 |
Amitryptilin |
1 |
1 |
T |
1 |
amphotericin B |
2 |
2 |
2 |
2 |
Antidiabetics, oral |
K |
K |
K |
K |
Atropine |
1/E |
1/E |
1/E |
1/E |
Benzyl benzoate (external use) |
1 |
1 |
1 |
1 |
ß-receptor blockers |
1 |
1 |
E |
1/2 |
ß-Sympathomimetics (for inhalation) |
1 |
1 |
E |
1 |
Biperidine |
2 |
2 |
2 |
2 |
Bromhexine |
1 |
1 |
1 |
1 |
Bromocriptine |
2 |
T |
T |
T/E |
Carbamazepine |
T |
2 |
T |
T |
Carbimazole |
2 |
2 |
2 |
2 |
Cephalosporins |
1 |
1 |
1 |
1 |
Cetirizine |
2 |
2 |
2 |
1 |
Chloramphenicol |
T |
T |
T |
T |
Chloroquine (antimalarial agent) |
1 |
1 |
1 |
1 |
Chlorphenoxamine (external application) |
1 |
1 |
1 |
1 |
Chlorpromazine |
2 |
2 |
T |
2 |
Cimetidine |
2 |
2 |
2 |
2 |
Ciprofloxacin |
2 |
2 |
2 |
2 |
Clarithromycin |
2 |
2 |
2 |
2 |
Clemastine |
1 |
1 |
1 |
2 |
Clofibrate |
2 |
2 |
2 |
2 |
Clomethiazole |
2 |
2 |
2 |
2 |
Clonidine |
2 |
2 |
2 |
2 |
Clotrimazole |
2 |
1 |
1 |
1 |
Codeine |
1/E |
1/E |
1/E |
1/E |
Cotrimoxazole |
2 |
2 |
2 |
2 |
Cromoglicic acid |
1 |
1 |
1 |
1 |
Coumarin derivatives |
K |
2 |
K |
2 |
Cyproterone acetate |
K |
K |
K |
K |
1 = 1st choice product: Generally well tolerated during pregnancy and lactation. Also, these drugs should only be prescribed if their use is superior to a non-drug therapy. 2 = 2nd choice remedy: Only indicated when other therapeutic options fail. Often insufficient testing during pregnancy and lactation. E = Single dose or low dosage for a maximum of 1-3 days. K = Contraindicated: Because of embryo-fetotoxic potential, possible intolerance during lactation or because there is no rational indication during pregnancy. Extended prenatal diagnosis may be necessary. T = Potentially toxic: Concerns embryo, foetus, newborn or breastfed infant. Use only in justified individual cases. In case of use, extended prenatal diagnostics may be necessary. |
Pharmaceuticals |
Embryonic period (1st-12th week of gestation) |
Fetal period (from 13th week of gestation) |
Peripartum period |
Lactation period |
Dextran |
2 |
2 |
2 |
2 |
Diazepam |
1 |
1/E |
T |
T |
Diclofenac |
1 |
T/E |
T/E |
E |
Digoxin/digitoxin |
1 |
1 |
1 |
1 |
Dihydralazine |
1 |
1 |
1 |
1 |
Dihydroergotamine |
2 |
2 |
T |
2 |
Dimenhydrinate |
2 |
2 |
2 |
1 |
Dimetinden |
1 |
1 |
1 |
1 |
Diphenhydramine |
1 |
1 |
T |
1/E |
Doxycycline |
2 |
K |
K |
2 |
Doxylamine |
1 |
1 |
1 |
1 |
Ergotamine tartrate |
T |
T |
T |
T |
Erythromycin |
1 |
1 |
1 |
1 |
Ethambutol |
1 |
1 |
1 |
1 |
Etilefrin |
2 |
2 |
2 |
2 |
Fenbufen |
1 |
T/E |
T/E |
1 |
Fentanyl |
1 |
1 |
T |
2 |
Fluconazole |
2 |
2 |
2 |
2 |
Furosemide |
2 |
2 |
2 |
2 |
Gestagens (used as contact pills during lactation) |
K |
K |
K |
1 |
Glucocorticoids |
2 |
2 |
2 |
2 |
Glycerol trinitrate |
2 |
2 |
2 |
2 |
Gold compounds |
2 |
2 |
2 |
2 |
Griseofulvin |
2 |
2 |
2 |
2 |
Haloperidol |
2 |
2 |
T |
2 |
Heparins |
1 |
1 |
T |
1 |
Hydrochlorothiazide |
2 |
2 |
2 |
2 |
Hydroxyethyl starch |
1 |
1 |
1 |
1 |
Ibuprofen |
1 |
T/E |
T/E |
1 |
Imipramine |
1 |
1 |
T |
1 |
Indomethacin |
1 |
T/E |
T/E |
E |
Insulin (human) |
1 |
1 |
1 |
1 |
isoniazid + vitamin B6 |
1 |
1 |
1 |
1 |
Isotretinoin |
K |
K |
K |
K |
Itraconazole |
2 |
2 |
2 |
2 |
Iodide (iodine substitution) |
1 |
1 |
1 |
1 |
Ketoconazole |
2 |
2 |
2 |
2 |
Lithium salts |
T |
T |
T |
T |
Local anaesthetics |
1 | 1 | 1 | 1 |
Loratadine |
2 |
2 |
2 |
1 |
Mebendazole |
2 |
1 |
1 |
1 |
Meclizine |
1 |
1 |
1 |
1 |
Mefloquine (malaria prophylaxis and therapy) |
2 |
2 |
2 |
2 |
Metamizole |
2 |
T |
T |
T |
Methimazol |
2 |
2 |
2 |
2 |
α-Methyldopa |
1 |
1 |
1 |
1 |
Methylergometrin |
K |
K |
T |
T/E |
Metoclopramide |
2 |
2 |
2 |
2 |
Miconazole (local) |
2 |
2 |
2 |
2 |
1 = 1st choice product: Generally well tolerated during pregnancy and lactation. Also, these drugs should only be prescribed if their use is superior to a non-drug therapy. 2 = 2nd choice remedy: Only indicated when other therapeutic options fail. Often insufficient testing during pregnancy and lactation. E = Single dose or low dosage for a maximum of 1-3 days. K = Contraindicated: Because of embryo-fetotoxic potential, possible intolerance during lactation or because there is no rational indication during pregnancy. Extended prenatal diagnosis may be necessary. T = Potentially toxic: Concerns embryo, foetus, newborn or breastfed infant. Use only in justified individual cases. In case of use, extended prenatal diagnostics may be necessary. |
Pharmaceuticals |
Embryonic period (1st-12th week of gestation) |
Fetal period (from 13th week of gestation) |
Peripartum period |
Lactation period |
Nifedipine |
2 |
2 |
2 |
1 |
Nitrendipine |
2 |
2 |
2 |
2 |
Nitrofurantoin |
2 |
2 |
2 |
2 |
Norfenefrin |
2 |
2 |
2 |
2 |
norfloxacin |
2 |
2 |
2 |
2 |
Nystatin |
1 |
1 |
1 |
1 |
Estrogens |
K |
K |
K |
2 |
Ofloxacin |
2 |
2 |
2 |
2 |
Opium alkaloids |
1/E |
1/E |
T/E |
T/E |
Oxytocin |
K |
K |
1 |
1 |
Paracetamol |
1 |
1 |
1 |
1 |
Penicillamine (except M. Wilson) |
K |
K |
K |
K |
Penicillin |
1 |
1 |
1 |
1 |
Pentazocin |
2 |
2 |
T |
2 |
Pethidine |
2 |
2 |
T |
2 |
Phenobarbital (as an anticonvulsant) |
T |
2 |
T |
T |
Phenylbutazone |
2 |
T |
T |
2 |
Phenytoin |
T |
T |
T |
1 |
Polyvidon iodine (except small areas) |
K |
K |
K |
K |
Prazosin |
2 |
2 |
2 |
2 |
Primidone |
T |
2 |
T |
T |
Probenecid |
1 |
1 |
1 |
1 |
Proguanil (malaria prophylaxis) |
1 |
1 |
1 |
1 |
Promethazine |
2 |
2 |
T |
2 |
Propylthiouracil |
1 |
1 |
1 |
1 |
Prostaglandins |
K |
K |
E |
K |
Pyrethrum (external) |
1 |
1 |
1 |
1 |
Pyrimethamine |
2 |
2 |
T |
1 |
Pyrvinium Emboat |
1 |
1 |
1 |
1 |
Ranitidine |
2 |
2 |
2 |
2 |
Radiopharmaceuticals |
K |
K |
K |
K |
Rifampicin |
1 |
1 |
1 |
1 |
Spironolactone |
2 |
2 |
2 |
2 |
Sulfonamides |
2 |
2 |
T |
2 |
Terfenadine |
2 |
2 |
2/E |
2/E |
Testosterone |
K |
K |
K |
K |
Tetracyclines |
2 |
K |
K |
2 |
Theophylline |
1 |
1 |
1 |
1 |
Thiamazole |
2 |
2 |
2 |
2 |
Thyroxine (L-) |
1 |
1 |
1 |
1 |
Tinidazole |
2/E |
2/E |
2/E |
2/E |
Tramadol |
2 |
2 |
T/E |
2/E |
Tretinoin (external) |
K |
K |
K |
2 |
Valproic acid |
T |
T |
T |
1 |
Verapamil |
2 |
2 |
2 |
1 |
Vitamin A (> 10,000 IU/day) |
K |
K |
K |
K |
1 = 1st choice product: Generally well tolerated during pregnancy and lactation. Also, these drugs should only be prescribed if their use is superior to a non-drug therapy. 2 = 2nd choice remedy: Only indicated when other therapeutic options fail. Often insufficient testing during pregnancy and lactation. E = Single dose or low dosage for a maximum of 1-3 days. K = Contraindicated: because of embryo-fetotoxic potential, possible intolerance during lactation or because there is no rational indication during pregnancy. Extended prenatal diagnosis may be necessary. T = Potentially toxic: Concerns embryo, foetus, newborn or breastfed infant. Use only in justified individual cases. In case of use, extended prenatal diagnostics may be necessary. |
Pharmaceuticals |
Indication during pregnancy |
|
Antimycotics |
Amorolfin |
3 |
amphotericin B |
1 |
|
Bifonazole |
2 |
|
Ciclopirox |
3 |
|
Clotrimazole |
1 |
|
Croconazole |
2 |
|
Econazole |
2 |
|
Fenticonazole |
2 |
|
Fluconazole |
2 |
|
Isoconazole |
2 |
|
Ketoconazole |
2 |
|
Naftifin |
3 |
|
Nystatin |
1 |
|
Sertaconazole |
2 |
|
Terbinafine |
3 |
|
Tioconazole |
2 |
|
Tolciclat |
3 |
|
Tolnoftat |
3 |
|
| ||
Glucocorticoids |
Glucocorticoids (topical application forms of various active substance classes such as ointments/creams/sg./gels) |
No objections to local therapy limited in time and space |
| ||
Antiparasitosa |
Allethrin I |
2 |
Benzyl benzoate |
1 |
|
Crotamiton |
2 |
|
Coconut oil |
1 |
|
Lindane |
banned in Germany since 2008! |
|
Pyrethrin |
2 |
|
Pyrethrum extract |
1 |
|
| ||
vitamin D3 analogues |
Calcipotriol |
Repeated applications over large areas should be avoided, especially if the effect is favourable to absorption |
Dithranol |
Repeated applications over large areas should be avoided, especially if the effect is favourable to absorption |
|
| ||
Other | ||
5-fluorouracil |
Contraindicated (Exception: therapy of single verrucae. In principle, however, an attempt should be made to postpone the therapy until after delivery) |
|
aluminium aceticum |
1 |
|
Ammonium bituminosulfonate |
No objections to local therapy limited in time and space |
|
Ethanol |
1 |
|
Benzoyl peroxide |
May be used for acne treatment of limited areas (e.g. face) |
|
Bufexamac |
No objections to local therapy limited in time and space |
|
Quinolinol |
Should not be used |
|
Clioquinol |
No objections to local therapy limited in time and space |
|
Diethyltoluamide (DEET, Autan) |
No safe large-scale application during pregnancy. In malaria areas, the risk associated with the use of DEET is less than the risk of malaria infection |
|
Haemorrhoid remedies |
Harmless. The application has been proven safe during pregnancy |
|
Urea |
No objections to local therapy limited in time and space |
|
Isopropyl alcohol |
1 |
|
Camphor |
Allowed |
|
Crystal Violet |
Small and short-term topical applications are possible |
|
Menthol |
Allowed |
|
Methylrosanilinium chloride (gentian violet) |
Small and short-term topical applications are possible |
|
pix lithanthracis |
Do not use if possible |
|
Polidocanol |
Allowed |
|
PUVA therapy (PUVA bath, cream-PUVA) |
Not recommended due to possible mutagenic effects |
|
Pyoctanin |
Small and short-term topical applications are possible |
|
Mercury compounds |
Contraindicated |
|
Retinoids |
Contraindicated |
|
Salicylates |
No objections to local therapy limited in time and space |
|
Tannin |
1 |
|
1 = 1st choice product: Generally well tolerated during pregnancy. Also, only prescribe these drugs if their use is superior to a non-drug therapy. 2 = 2nd choice remedy: Only indicated if other therapeutic options fail. Often insufficient testing during pregnancy and lactation. 3 = Agents which should not be used during pregnancy due to insufficient data or for other reasons. |
|
Largely harmless |
After risk-benefit analysis |
Contraindicated |
Pregnancy |
Penicillins, cephalosporins, erythromycin (except estolate), fusidic acid |
Clavulanic acid, sulbactam, tazobactam, meropenem, imipenem, ertapenem, azithromycin, roxithromycin, clindamycin, vancomycin, teicoplanin, linezolid, fosfomycin |
Tetracyclines, chloramphenicol, clarithromycin, TMP/sulfonamides (1st trimester and from 28th week), metronidazole, aminoglycosides, fluoroquinolones, nitrofurantoin, rifampicin, telithromycin, tigecyclin |
Breastfeeding period |
penicillins, cephalosporins |
Clavulanic acid, sulbactam, tazobactam, meropenem, imipenem, ertapenem, azithromycin, roxithromycin, clindamycin, vancomycin, teicoplanin, linezolid, aminoglycosides, fosfomycin |
Tetracyclines, chloramphenicol, TMP/sulfonamides, erythromycin, metronidazole, fluoroquinolones, nitrofurantoin, rifampicin, telithromycin, ertapenem, tigecyclin |